DROSPIRENONE; ETHINYL ESTRADIOL | A201663 | LUPIN LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Bayer Schering Pharma AG et al v. Lupin Ltd. et al 3 patentsANDA 201663drospirenone and ethinyl estradiol | S.D.N.Y. | 2010-07-15 | Terminated 2010-12-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1538
per ea
Lowest NADAC/Unit
$0.1538
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68180086873DROSPIRENONE-EE 3-0.03 MG TAB | $0.1538 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.